ZA986580B - Aminoethylphenoxyacetic acid derivatives and agents for relieving pain and promoting the removal of calculi in urolithiasis - Google Patents

Aminoethylphenoxyacetic acid derivatives and agents for relieving pain and promoting the removal of calculi in urolithiasis

Info

Publication number
ZA986580B
ZA986580B ZA986580A ZA986580A ZA986580B ZA 986580 B ZA986580 B ZA 986580B ZA 986580 A ZA986580 A ZA 986580A ZA 986580 A ZA986580 A ZA 986580A ZA 986580 B ZA986580 B ZA 986580B
Authority
ZA
South Africa
Prior art keywords
urolithiasis
calculi
promoting
agents
removal
Prior art date
Application number
ZA986580A
Other languages
English (en)
Inventor
Tetsuro Tamai
Nobuyuki Tanaka
Hideyuki Muranaka
Harunobu Mukaiyama
Akihito Hirabayashi
Masaaki Sato
Masuo Akahane
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of ZA986580B publication Critical patent/ZA986580B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA986580A 1997-07-25 1998-07-23 Aminoethylphenoxyacetic acid derivatives and agents for relieving pain and promoting the removal of calculi in urolithiasis ZA986580B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23323997 1997-07-25

Publications (1)

Publication Number Publication Date
ZA986580B true ZA986580B (en) 1999-02-04

Family

ID=16951956

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986580A ZA986580B (en) 1997-07-25 1998-07-23 Aminoethylphenoxyacetic acid derivatives and agents for relieving pain and promoting the removal of calculi in urolithiasis

Country Status (29)

Country Link
US (1) US6399660B1 (xx)
EP (1) EP1002791B1 (xx)
JP (1) JP4002391B2 (xx)
KR (1) KR100545473B1 (xx)
CN (1) CN1137877C (xx)
AR (1) AR013241A1 (xx)
AT (1) ATE280146T1 (xx)
AU (1) AU754579B2 (xx)
BR (1) BR9811483B1 (xx)
CA (1) CA2298493C (xx)
CO (1) CO4970779A1 (xx)
CZ (1) CZ300389B6 (xx)
DE (1) DE69827137T2 (xx)
ES (1) ES2231996T3 (xx)
HK (1) HK1028016A1 (xx)
HU (1) HUP0004055A3 (xx)
ID (1) ID24062A (xx)
IL (1) IL133863A0 (xx)
MY (1) MY126743A (xx)
NO (1) NO315422B1 (xx)
NZ (1) NZ502366A (xx)
PE (1) PE99899A1 (xx)
PL (1) PL191864B1 (xx)
PT (1) PT1002791E (xx)
RU (1) RU2196130C2 (xx)
SA (1) SA98190661B1 (xx)
TW (1) TW418184B (xx)
WO (1) WO1999005090A1 (xx)
ZA (1) ZA986580B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4212771B2 (ja) 1998-04-14 2009-01-21 キッセイ薬品工業株式会社 ２−メチルプロピオン酸誘導体および当該誘導体を含有する医薬組成物
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
DE60024053T2 (de) * 1999-01-21 2006-07-20 Kissei Pharmaceutical Co., Ltd., Matsumoto Kristall-polymorphismus von derivaten der aminoethylphenoxyessigsäure
CA2479254A1 (en) * 2002-03-22 2003-10-02 Kissei Pharmaceutical Co., Ltd. Preventive or therapeutic agent for renal disease
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
DE10333569A1 (de) * 2003-07-23 2005-02-17 Z & J Technologies Gmbh Einrichtung zur Verteilung von Schüttgut in wenigstens zwei oberhalb der Gicht eines Hochofens angeordnete Bunker
JP4843313B2 (ja) * 2004-02-12 2011-12-21 キッセイ薬品工業株式会社 食道の運動障害を伴う疾患の予防または治療用医薬組成物
WO2007004639A1 (ja) * 2005-07-06 2007-01-11 Daiichi Fine Chemical Co., Ltd. 光学活性エリスロ-β-アミノアルコールの製法
AU2006285963A1 (en) * 2005-08-29 2007-03-08 Kissei Pharmaceutical Co., Ltd. Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
ES2302447B1 (es) * 2006-10-20 2009-06-12 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3061334D1 (en) * 1979-06-16 1983-01-20 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
ES2195021T3 (es) * 1995-11-30 2003-12-01 Kissei Pharmaceutical Medicamento para aliviar el dolor y favorecer la eliminacion de calculos en la urolitiasis.
AU4320297A (en) * 1996-09-26 1998-04-17 Kissei Pharmaceutical Co. Ltd. 2-amino-1-(4-hydroxy-2-methylphenyl)propanol derivatives

Also Published As

Publication number Publication date
ATE280146T1 (de) 2004-11-15
EP1002791A1 (en) 2000-05-24
EP1002791B1 (en) 2004-10-20
HUP0004055A2 (hu) 2001-04-28
SA98190661B1 (ar) 2006-09-09
RU2196130C2 (ru) 2003-01-10
KR20010022124A (ko) 2001-03-15
HUP0004055A3 (en) 2001-10-29
AU754579B2 (en) 2002-11-21
CZ2000272A3 (cs) 2000-05-17
PL191864B1 (pl) 2006-07-31
DE69827137T2 (de) 2006-03-09
HK1028016A1 (en) 2001-02-02
ID24062A (id) 2000-07-06
PE99899A1 (es) 1999-11-11
EP1002791A4 (en) 2001-09-12
CN1137877C (zh) 2004-02-11
MY126743A (en) 2006-10-31
AU8241998A (en) 1999-02-16
NO20000371L (no) 2000-01-25
PT1002791E (pt) 2005-01-31
US6399660B1 (en) 2002-06-04
TW418184B (en) 2001-01-11
CO4970779A1 (es) 2000-11-07
BR9811483B1 (pt) 2009-01-13
AR013241A1 (es) 2000-12-13
PL338234A1 (en) 2000-10-09
BR9811483A (pt) 2000-09-19
IL133863A0 (en) 2001-04-30
KR100545473B1 (ko) 2006-01-24
ES2231996T3 (es) 2005-05-16
CA2298493C (en) 2008-03-18
DE69827137D1 (de) 2004-11-25
WO1999005090A1 (fr) 1999-02-04
CN1265091A (zh) 2000-08-30
NO20000371D0 (no) 2000-01-25
CA2298493A1 (en) 1999-02-04
JP4002391B2 (ja) 2007-10-31
NZ502366A (en) 2004-12-24
CZ300389B6 (cs) 2009-05-06
NO315422B1 (no) 2003-09-01

Similar Documents

Publication Publication Date Title
IL125981A0 (en) Improved tissue destruction in cryosurgery
HU9700602D0 (en) New inhibitors of bone-resorption and vitronectine-receptor-antagonists
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
HRP20000201B1 (en) Prostaglandin agonists and their use to treat bone disorders
IL139030A0 (en) Therapeutic angiogenic factors and methods for their use
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
IL138732A0 (en) The use of polyamines in the treatment of dermatological symptoms
IL120687A0 (en) Handpiece for use in lithotripsy
PL334662A1 (en) Terbenzimidazoles (inhibitors of topisomerase) useful in medical therapy
PL335555A1 (en) Novel compounds - substituted benzamides and therapeutic agent
HUP0002030A3 (en) Use of glur5 receptorantagonists for the treatment of pain
ZA986580B (en) Aminoethylphenoxyacetic acid derivatives and agents for relieving pain and promoting the removal of calculi in urolithiasis
HUP0000963A3 (en) The use of levobupivacaine in paediatric surgery
IL115224A0 (en) Preparations for use in the treatment of osteoporosis
AP9901573A0 (en) Chip card and process for the use of the chip card
EP0750511A4 (en) TREATMENT OF INFLAMMATION BY ADMINISTRATION OF SPECIFIC SULFATASE ENZYMES AND / OR A SULFATATION INHIBITOR
AU7688998A (en) Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
HUP0004510A3 (en) Process for obtaining l-dihydroorotic acid and use thereof
ZA969586B (en) The use of cholinesterase inhibitors in the treatment of xerostomia
PL327137A1 (en) Pain relieving agent
HUP9902802A3 (en) Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
PL336592A1 (en) Application of oligosaccharides in treating connective tissue
AU2713797A (en) Depigmentating agent in the treatment of melasma
GB9617346D0 (en) Therapeutic methods and compositions for use therein
GB2333045B (en) Swab for use in acupuncture